Yongchen Hao Selected Research

Yongchen Hao Research Topics

Disease

17	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 05/2012
17	Acute Coronary Syndrome 12/2023 - 01/2018
10	Hemorrhage 12/2023 - 01/2018
7	ST Elevation Myocardial Infarction 01/2023 - 01/2019
6	Myocardial Infarction 07/2023 - 01/2019
4	Thrombosis (Thrombus) 11/2022 - 11/2019
4	Coronary Disease (Coronary Heart Disease) 11/2015 - 08/2011
3	Atrial Fibrillation 12/2023 - 01/2018
3	Stroke (Strokes) 12/2023 - 11/2019
3	Heart Failure 01/2022 - 11/2019
3	Hypertension (High Blood Pressure) 01/2022 - 01/2016
2	Cardiogenic Shock 01/2022 - 09/2021
2	Heart Arrest (Cardiac Arrest) 01/2022 - 09/2021
1	Thrombocytopenia (Thrombopenia) 12/2023
1	Acute Kidney Injury (Acute Renal Failure) 07/2023
1	Cardiac Arrhythmias (Arrythmia) 07/2023
1	Ischemia 07/2023
1	Wounds and Injuries (Trauma) 07/2023
1	Left Ventricular Dysfunction 01/2023
1	Atherosclerotic Plaque (Atheroma) 01/2023
1	Tachycardia (Tachyarrhythmias) 12/2021
1	Atrial Flutter (Flutter, Atrial) 12/2021
1	Ischemic Stroke 01/2020
1	Anemia 01/2020
1	Death (Near-Death Experience) 01/2020
1	Chest Pain (Chest Pains) 11/2019
1	Hemorrhagic Stroke 09/2018
1	Neoplasms (Cancer) 09/2018
1	Atherosclerosis 11/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2016
1	Genetic Risk Score 02/2016
1	Hyperlipidemias (Hyperlipidemia) 02/2016
1	Dyslipidemias (Dyslipidemia) 11/2011

Drug/Important Bio-Agent (IBA)

7	LDL CholesterolIBA 11/2022 - 09/2018
6	oxidized low density lipoproteinIBA 11/2022 - 09/2018
5	LipidsIBA 09/2022 - 11/2011
4	omega-Chloroacetophenone (Mace)IBA 12/2023 - 11/2019
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 11/2015
3	TicagrelorIBA 11/2022 - 01/2020
3	Clopidogrel (Plavix)FDA Link 11/2022 - 01/2020
3	CholesterolIBA 09/2022 - 11/2015
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2021
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2023 - 01/2023
2	Angiotensin Receptor AntagonistsIBA 02/2023 - 01/2023
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2022 - 01/2020
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 09/2021
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2021 - 01/2020
2	VLDL CholesterolIBA 11/2017 - 11/2015
2	AdiponectinIBA 06/2013 - 05/2012
1	CoagulantsIBA 12/2023
1	LatexIBA 01/2023
1	Lipoprotein(a)IBA 01/2023
1	Platelet Membrane GlycoproteinsIBA 11/2022
1	HDL CholesterolIBA 09/2022
1	Bisoprolol (Concor)FDA LinkGeneric 06/2022
1	Metoprolol (Toprol-XL)FDA LinkGeneric 06/2022
1	CalciumIBA 01/2022
1	Proton Pump InhibitorsIBA 01/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	DiureticsIBA 12/2021
1	Platelet Membrane Glycoprotein IIbIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	pro-brain natriuretic peptide (1-76)IBA 01/2020
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 11/2019
1	Messenger RNA (mRNA)IBA 11/2017
1	VLDL LipoproteinsIBA 11/2017
1	Apolipoproteins E (ApoE)IBA 02/2016
1	lyxoseIBA 01/2016
1	Amino Acids FDA Link 01/2016
1	ORALIT (ORS)IBA 05/2012
1	Fibric Acids (Fibrates)IBA 11/2011
1	Factor VII (Proconvertin)IBA 08/2011

Therapy/Procedure

18	Therapeutics 12/2023 - 01/2018
8	Percutaneous Coronary Intervention 12/2023 - 01/2018
3	Stents 09/2021 - 11/2019
1	Length of Stay 07/2023
1	Contraindications 06/2022
1	Cardiopulmonary Resuscitation (CPR) 01/2022
1	Secondary Prevention 01/2019